A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes ...

The rStar2-Agent framework boosts a 14B model to outperform a 671B giant, offering a path to state-of-the-art AI without ...

Replit, the company that turned coding into something you could do from a browser tab, has just raised $250 million in new ...